[Therapeutic evaluation of cephalexin monohydrate in 25 patients with otorhinolaryngologic disorders].
D000293:Adolescent; D000328:Adult; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007818:Laryngeal Diseases / Q000188:drug therapy; D008297:Male; D010031:Otitis / Q000188:drug therapy*; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D010608:Pharyngeal Diseases / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy
D002511:Cephalosporins
Valoración terapéutica del monohidrato de cefalexina en 25 pacientes con padecimientos otorrinolaringológicos.